ScholarGate
アシスタント

手法を比較

選択した手法を並べて確認できます。異なる行はハイライト表示されます。

EORTC QLQ-LC13:肺癌における生活の質×Cancer Worry Scale: 心理的苦痛を測定するがんケアにおける尺度×
分野腫瘍学腫瘍学
系統Process / pipelineProcess / pipeline
提唱年19941991
提唱者Bergman, B., et al. (EORTC Quality of Life Group)Lerman, C., et al.
種類Self-report questionnaireSelf-report questionnaire
原典Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol, 10(1), 259–267. DOI ↗
別名QLQ-LC13CWS
関連55
概要The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.The Cancer Worry Scale (CWS) is a brief 8-item instrument assessing the degree to which cancer-related worry interferes with daily functioning and emotional well-being. Developed by Lerman et al. in 1991, it quantifies cancer-related anxiety and distress—psychological burden distinct from symptom burden and functional impairment. It is widely used in cancer screening, treatment, and survivorship contexts to identify patients requiring psychological support.
ScholarGateデータセット
  1. v1
  2. 2 出典
  3. PUBLISHED
  1. v1
  2. 1 出典
  3. PUBLISHED

検索へ スライドをダウンロード

ScholarGate手法を比較: EORTC QLQ-LC13 · Cancer Worry Scale. 2026-06-19に以下より取得 https://scholargate.app/ja/compare